Focused Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Buy
+1,100
New +$1.12M 0.11% 75
2024
Q1
– Sell
-600
Closed -$4.51K – 613
2023
Q4
$4.51K Buy
+600
New +$350K ﹤0.01% 668

Other funds holding LLY

Focused Wealth Management's LLY Position: Q2 2026 in Review

Focused Wealth Management increased its Eli Lilly (LLY) stake by 34% in Q2 2026, buying an estimated $568K and bringing the position to 2,178 shares worth $2.61M. The position accounts for 0.23% of the portfolio, ranked #51.

Focused Wealth Management first reported a position in LLY in Q3 2013 and has held it in 52 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Focused Wealth Management held 2,178 shares of Eli Lilly worth $2.61M as of Q2 2026.
  • Focused Wealth Management bought 556 Eli Lilly shares in Q2 2026, an estimated $568K.
  • Eli Lilly made up 0.23% of Focused Wealth Management's portfolio in Q2 2026, its #51 holding.
  • Focused Wealth Management first reported a position in Eli Lilly in Q3 2013 and has held it in 52 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Focused Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.